Literature DB >> 11792391

Enhanced in vitro stimulation of rhesus macaque dendritic cells for activation of SIV-specific T cell responses.

Erin Mehlhop1, Loreley A Villamide, Ines Frank, Agegnehu Gettie, Christine Santisteban, Davorka Messmer, Ralf Ignatius, Jeffrey D Lifson, Melissa Pope.   

Abstract

The macaque-simian immunodeficiency virus (SIV) system is one of the best animal models available to study the role of dendritic cells (DCs) in transmission and pathogenesis of HIV, as well as to test DC-based vaccine and therapeutic strategies. To better define and optimize this system, the responsiveness of macaque monocyte-derived DCs to a variety of maturation stimuli was examined. Characteristic immunophenotypic and functional DC maturation induced by standard monocyte conditioned medium (MCM) was compared to the activation induced by a panel of stimuli including soluble CD40L, LPS, Poly I:C, PGE(2)/TNFalpha, and a cocktail mixture of PGE(2)/TNFalpha/IL-1beta/IL-6. Immunophenotypic analysis confirmed that all stimuli induced stable up-regulation of CD25, CD40, CD80, CD83, CD86, HLA-DR, DC-LAMP (CD208), and DEC-205 (CD205). In general, macaque DCs exhibited weaker responses to LPS and Poly I:C than human DCs, and soluble CD40L stimulation induced variable expression of CD25. Interestingly, while the endocytic capacity of CD40L-matured cells was down-modulated comparably to DCs matured with MCM or the cocktail, the T cell stimulatory activity was not enhanced to the same extent. The particularly reproducible and potent T cell stimulatory capacity of cocktail-treated DCs correlated with a more homogenous mature DC phenotype, consistently high levels of IL-12 production, and better viability upon reculture compared to DCs activated by other stimuli. Furthermore, cocktail-matured DCs efficiently captured and presented inactivated SIV to SIV-primed T cells in vitro. Thus, the cocktail represents a particularly potent and useful stimulus for the generation of efficacious immunostimulatory macaque DCs.

Entities:  

Mesh:

Year:  2002        PMID: 11792391     DOI: 10.1016/s0022-1759(01)00544-0

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  19 in total

1.  Evidence for antibody-mediated enhancement of simian immunodeficiency virus (SIV) Gag antigen processing and cross presentation in SIV-infected rhesus macaques.

Authors:  Francois Villinger; Ann E Mayne; Pavel Bostik; Kazuyasu Mori; Peter E Jensen; Rafi Ahmed; Aftab A Ansari
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

2.  Antigen capture of Porphyromonas gingivalis by human macrophages is enhanced but killing and antigen presentation are reduced by endotoxin tolerance.

Authors:  Manoj Muthukuru; Christopher W Cutler
Journal:  Infect Immun       Date:  2007-11-12       Impact factor: 3.441

3.  A fusion inhibitor prevents spread of immunodeficiency viruses, but not activation of virus-specific T cells, by dendritic cells.

Authors:  I Frank; H Stössel; A Gettie; S G Turville; J W Bess; J D Lifson; I Sivin; N Romani; M Robbiani
Journal:  J Virol       Date:  2008-03-26       Impact factor: 5.103

Review 4.  Synthetic DNA vaccine strategies against persistent viral infections.

Authors:  Daniel O Villarreal; Kendra T Talbott; Daniel K Choo; Devon J Shedlock; David B Weiner
Journal:  Expert Rev Vaccines       Date:  2013-05       Impact factor: 5.217

5.  Loss of naive T cells and repertoire constriction predict poor response to vaccination in old primates.

Authors:  Luka Cicin-Sain; Susan Smyk-Pearson; Sue Smyk-Paerson; Noreen Currier; Laura Byrd; Caroline Koudelka; Tammie Robinson; Gwendolyn Swarbrick; Shane Tackitt; Alfred Legasse; Miranda Fischer; Dragana Nikolich-Zugich; Byung Park; Theodore Hobbs; Cynthia J Doane; Motomi Mori; Michael K Axthelm; Michael T Axthelm; Deborah A Lewinsohn; Janko Nikolich-Zugich
Journal:  J Immunol       Date:  2010-05-17       Impact factor: 5.422

6.  Elimination of retroviral infectivity by N-ethylmaleimide with preservation of functional envelope glycoproteins.

Authors:  David R Morcock; James A Thomas; Tracy D Gagliardi; Robert J Gorelick; J David Roser; Elena N Chertova; Julian W Bess; David E Ott; Quentin J Sattentau; Ines Frank; Melissa Pope; Jeffrey D Lifson; Louis E Henderson; Bruce J Crise
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

Review 7.  Simian immunodeficiency virus interactions with macaque dendritic cells.

Authors:  Natalia Teleshova; Nina Derby; Elena Martinelli; Pavel Pugach; Giulia Calenda; Melissa Robbiani
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

8.  Immunomodulatory effects of HSV-2 infection on immature macaque dendritic cells modify innate and adaptive responses.

Authors:  Silvia Peretti; Andrew Shaw; James Blanchard; Rudolf Bohm; Gavin Morrow; Jeffrey D Lifson; Agegnehu Gettie; Melissa Pope
Journal:  Blood       Date:  2005-04-21       Impact factor: 22.113

9.  Increased macrophage infection upon subcutaneous inoculation of rhesus macaques with simian immunodeficiency virus-loaded dendritic cells or T cells but not with cell-free virus.

Authors:  Ralf Ignatius; Klara Tenner-Racz; Davorka Messmer; Agegnehu Gettie; James Blanchard; Amara Luckay; Christine Russo; Stephen Smith; Preston A Marx; Ralph M Steinman; Paul Racz; Melissa Pope
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

10.  Noninfectious X4 but not R5 human immunodeficiency virus type 1 virions inhibit humoral immune responses in human lymphoid tissue ex vivo.

Authors:  Wendy Fitzgerald; Andrew W Sylwester; Jean-Charles Grivel; Jeffrey D Lifson; Leonid B Margolis
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.